Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR stock logo
CHGCY
Chugai Pharmaceutical
$24.68
-1.5%
$26.68
$18.39
$31.26
$82.47B0.66163,436 shs63,001 shs
Elevance Health, Inc. stock logo
ELV
Elevance Health
$350.34
-11.5%
$390.70
$349.62
$567.26
$89.42B0.61.60 million shs4.80 million shs
McKesson Corporation stock logo
MCK
McKesson
$705.68
-3.0%
$713.06
$464.42
$736.96
$91.05B0.48924,562 shs731,881 shs
Olympus Co. stock logo
OCPNY
Olympus
$18.00
-1.4%
$18.00
$16.80
$74.99
$23.15B0.7860,265 shs400 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR stock logo
CHGCY
Chugai Pharmaceutical
-1.52%-5.26%-9.13%+10.38%+37.34%
Elevance Health, Inc. stock logo
ELV
Elevance Health
-11.48%-6.38%-7.09%-22.61%-34.63%
McKesson Corporation stock logo
MCK
McKesson
-2.79%-1.88%-2.16%-1.54%+20.66%
Olympus Co. stock logo
OCPNY
Olympus
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR stock logo
CHGCY
Chugai Pharmaceutical
1.0449 of 5 stars
0.03.01.70.02.90.00.6
Elevance Health, Inc. stock logo
ELV
Elevance Health
4.9005 of 5 stars
4.43.04.20.02.22.53.1
McKesson Corporation stock logo
MCK
McKesson
4.721 of 5 stars
2.45.03.33.02.92.51.3
Olympus Co. stock logo
OCPNY
Olympus
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR stock logo
CHGCY
Chugai Pharmaceutical
0.00
N/AN/AN/A
Elevance Health, Inc. stock logo
ELV
Elevance Health
2.75
Moderate Buy$498.8742.40% Upside
McKesson Corporation stock logo
MCK
McKesson
2.86
Moderate Buy$696.42-1.31% Downside
Olympus Co. stock logo
OCPNY
Olympus
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest OCPNY, MCK, ELV, and CHGCY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/11/2025
McKesson Corporation stock logo
MCK
McKesson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$745.00 ➝ $770.00
6/9/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$510.00 ➝ $500.00
6/4/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$478.00
6/3/2025
McKesson Corporation stock logo
MCK
McKesson
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetEqual Weight ➝ Equal Weight$691.00 ➝ $766.00
6/2/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$522.00 ➝ $480.00
5/9/2025
McKesson Corporation stock logo
MCK
McKesson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$755.00 ➝ $800.00
4/29/2025
McKesson Corporation stock logo
MCK
McKesson
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$708.00 ➝ $805.00
4/25/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$465.00
4/23/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$478.00 ➝ $478.00
4/23/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$518.00 ➝ $518.00
4/23/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$485.00 ➝ $485.00
(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR stock logo
CHGCY
Chugai Pharmaceutical
$7.74B10.49$0.83 per share29.77$3.81 per share6.48
Elevance Health, Inc. stock logo
ELV
Elevance Health
$177.01B0.45$34.69 per share10.10$178.62 per share1.96
McKesson Corporation stock logo
MCK
McKesson
$359.05B0.25$37.68 per share18.73($13.52) per share-52.20
Olympus Co. stock logo
OCPNY
Olympus
$7.74B2.99$1.22 per share14.76$3.50 per share5.14
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR stock logo
CHGCY
Chugai Pharmaceutical
$2.56B$0.8130.4731.64N/A33.56%21.71%18.98%7/24/2025 (Estimated)
Elevance Health, Inc. stock logo
ELV
Elevance Health
$5.98B$25.6313.678.971.013.23%18.61%6.80%7/16/2025 (Estimated)
McKesson Corporation stock logo
MCK
McKesson
$3.30B$25.8327.3219.261.450.92%-201.12%5.83%8/6/2025 (Estimated)
Olympus Co. stock logo
OCPNY
Olympus
$1.03B$0.8221.9520.691.0713.80%24.30%9.30%N/A

Latest OCPNY, MCK, ELV, and CHGCY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/16/2025Q2 2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
$9.30N/AN/AN/A$48.26 billionN/A
5/8/2025Q4 2025
McKesson Corporation stock logo
MCK
McKesson
$9.83$10.12+$0.29$10.01$94.00 billion$90.82 billion
4/24/2025Q1 2025
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR stock logo
CHGCY
Chugai Pharmaceutical
N/A$0.19N/A$0.19N/A$1.89 billion
4/22/2025Q1 2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
$10.60$11.97+$1.37$9.61$46.26 billion$48.77 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR stock logo
CHGCY
Chugai Pharmaceutical
$0.261.05%N/A32.10%N/A
Elevance Health, Inc. stock logo
ELV
Elevance Health
$6.841.95%N/A26.69%14 Years
McKesson Corporation stock logo
MCK
McKesson
$2.840.40%N/A10.99%17 Years
Olympus Co. stock logo
OCPNY
Olympus
$0.080.44%N/A9.76%N/A

Latest OCPNY, MCK, ELV, and CHGCY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2025
McKesson Corporation stock logo
MCK
McKesson
quarterly$0.710.4%6/2/20256/2/20257/1/2025
4/23/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
quarterly$1.711.6%6/10/20256/10/20256/25/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR stock logo
CHGCY
Chugai Pharmaceutical
N/A
7.28
6.16
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.66
1.43
1.43
McKesson Corporation stock logo
MCK
McKesson
N/A
0.90
0.53
Olympus Co. stock logo
OCPNY
Olympus
0.59
1.99
1.48

Institutional Ownership

CompanyInstitutional Ownership
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR stock logo
CHGCY
Chugai Pharmaceutical
0.01%
Elevance Health, Inc. stock logo
ELV
Elevance Health
89.24%
McKesson Corporation stock logo
MCK
McKesson
85.07%
Olympus Co. stock logo
OCPNY
Olympus
0.03%

Insider Ownership

CompanyInsider Ownership
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR stock logo
CHGCY
Chugai Pharmaceutical
N/A
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.29%
McKesson Corporation stock logo
MCK
McKesson
0.11%
Olympus Co. stock logo
OCPNY
Olympus
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR stock logo
CHGCY
Chugai Pharmaceutical
7,7783.29 billionN/ANot Optionable
Elevance Health, Inc. stock logo
ELV
Elevance Health
104,200225.93 million225.28 millionOptionable
McKesson Corporation stock logo
MCK
McKesson
45,000125.11 million124.97 millionOptionable
Olympus Co. stock logo
OCPNY
Olympus
31,5571.29 billionN/ANot Optionable

Recent News About These Companies

Olympus Corporation (OLYMY) Q3 2025 Earnings Call Transcript
27 Olympus Way, Lyons ACT 2606
Olympus Teams Up With Sony for Surgical Big Screen TV
Overwatch 2 Battle for Olympus Event
Olympus Corporation (OCPNY) Q3 2022 Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

Chugai Pharmaceutical stock logo

Chugai Pharmaceutical OTCMKTS:CHGCY

$24.68 -0.38 (-1.52%)
As of 07/2/2025 03:59 PM Eastern

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances and collaboration with Roche Group. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd.

Elevance Health stock logo

Elevance Health NYSE:ELV

$350.34 -45.42 (-11.48%)
Closing price 07/2/2025 03:59 PM Eastern
Extended Trading
$359.29 +8.95 (+2.55%)
As of 07/2/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

McKesson stock logo

McKesson NYSE:MCK

$705.68 -22.06 (-3.03%)
Closing price 07/2/2025 03:59 PM Eastern
Extended Trading
$708.90 +3.22 (+0.46%)
As of 07/2/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Olympus stock logo

Olympus OTCMKTS:OCPNY

$18.00 -0.25 (-1.37%)
As of 01/31/2023

Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.